SCHEMBL8959346

SCHEMBL8959346

C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@]13C=C[C@]2(O)[C@H](O)C3

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.50
ESR2 Q92731 9/20 0.50
SHBG P04278 5/20 0.50
HSD17B10 Q99714 4/20 0.50
LMNA P02545 4/20 0.50
STS P08842 4/20 0.50
PGR P06401 4/20 0.50
AR P10275 4/20 0.50
SLC6A4 P31645 4/20 0.50
SLC6A3 Q01959 4/20 0.50
CYP3A4 P08684 4/20 0.50
HIF1A Q16665 3/20 0.50
SERPINA6 P08185 3/20 0.50
SNCA P37840 3/20 0.50
HTR2B P41595 3/20 0.50
NR3C1 P04150 3/20 0.50
TSHR P16473 2/20 0.50
CYP1A2 P05177 2/20 0.50
AKR1B10 O60218 2/20 0.50
MAPT P10636 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9146982 1.00 ESR1 (0.50) ESR1ESR2SHBGHSD17B10LMNA
SCHEMBL8959391 1.00 ESR1 (0.50) ESR1ESR2SHBGHSD17B10LMNA
SCHEMBL8959354 1.00 ESR1 (0.50) ESR1ESR2SHBGHSD17B10LMNA
SCHEMBL9147068 0.87 LMNA (0.53) ESR1ESR2HSD17B10LMNASTS
SCHEMBL8959344 0.87 LMNA (0.53) ESR1ESR2HSD17B10LMNASTS
SCHEMBL8959384 0.87 LMNA (0.53) ESR1ESR2HSD17B10LMNASTS
SCHEMBL9145265 0.84 SMN1; SMN2 (0.56) ESR1SHBGHSD17B10LMNASTS
SCHEMBL8959363 0.84 SMN1; SMN2 (0.56) ESR1SHBGHSD17B10LMNASTS
SCHEMBL9194648 0.81 HTR1A (0.35) ESR1HSD17B10LMNAHIF1AHTR2B
SCHEMBL9725114 0.81 ESR1 (0.50) ESR1ESR2SHBGHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0430386-B1 14Alpha, 17alpha bridged 16-hydroxyestratrienes SCHERING AG (DE) 1995-05-03 EP claimed
EP-0430386-A1 14Alpha, 17alpha bridged 16-hydroxyestratrienes SCHERING AKTIENGESELLSCHAFT (DE) 1991-06-05 EP claimed
US-5529993-A UROGENITAL DISORDERS; CONTRACEPTIVES SCHERING AKTIENGESELLSCHAFT (DE) 1996-06-25 US disclosed
EP-0430386-B1 14Alpha, 17alpha bridged 16-hydroxyestratrienes SCHERING AG (DE) 1995-05-03 EP disclosed
EP-0430386-A1 14Alpha, 17alpha bridged 16-hydroxyestratrienes SCHERING AKTIENGESELLSCHAFT (DE) 1991-06-05 EP disclosed